基于健康的潜在风险调整是否足够补偿被诊断患有新慢性疾病的个人?
Michel Oskam1, Richard C van Kleef1, René C J A van Vliet1
1Erasmus School of Health Policy & Management, Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Medical care research and review : MCRR
|November 14, 2025
概括
预期风险调整 (RA) 可能会为患有新慢性疾病的个人支付不足的医疗保险公司. 这种支付差距可以激励保险公司影响消费者选择,因为新诊断的个人更有可能更换保险计划.
科学领域:
- 卫生经济学 卫生经济学
- 保险市场监管 保险市场监管
- 公共卫生政策 公共卫生政策
背景情况:
- 监管的医疗保险市场使用前性风险调整 (RA) 来尽量减少保险公司的风险选择.
- 未来的RA模型可能无法充分补偿保险公司对新诊断患有慢性疾病的入学者的赔偿.
研究的目的:
- 对被诊断患有新慢性疾病的个人,调查未来RA的潜在支付差距.
- 评估这些支付差距对保险公司选择激励机制的影响.
- 分析消费者在应对慢性疾病诊断时的转换行为.
主要方法:
- 从t-2到t+2对支出和RA支付进行纵向分析.
- 追踪在t年被诊断患有新慢性疾病的个体.
- 在同一时期内分析"保险商更换"数据.
主要成果:
- 对于新诊断患有慢性疾病的个人,在t年发现了显著的支付差距,相邻年间的支付差距较小.
- 与其他人相比,新诊断患有慢性疾病的个人更倾向于更换保险公司.
- 这些发现表明,支付差距可能会影响保险商的行为和消费者选择.
结论:
- 未来的RA可能会为保险公司提供财务激励,以参与风险选择,特别是在新诊断的慢性疾病方面.
- 消费者对慢性疾病发病的反应,包括改变保险公司,在RA支付差距如何影响保险公司激励方面发挥着至关重要的作用.
- 对RA模型的政策调整可能是必要的,以确保公平的补偿和减轻选择激励措施.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
01:25Strategies for Assessing and Addressing Confounding
345
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
345
01:22Nursing Diagnosis
3.6K
Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
The nursing diagnosis focuses on evidence-based...
3.6K
01:12Relative Risk
1.8K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.8K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
244
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
244
01:29Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K